Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  American Heart Journal

• Publication date

  1976-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-8703(76)80043-9PMID 785990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma levels of individual free fatty acids in patients with acute myocardial infarction.

  2009cited by this paper
• The Protective Effect of Glucose‐Insulin‐Potassium on the Response to Atrial Pacing

  1976cited by this paper
• MALNUTRITION AND SCHOOL PROGRESS

  1975cited by this paper
• HUMAN PLACENTAL LACTOGEN IN SCREENING FOR MULTIPLE PREGNANCIES

  1975cited by this paper
• THYROTOXICOSIS DUE TO " SILENT " THYROIDITIS

  1975cited by this paper
• Initial metabolic and hormonal response to acute myocardial infarction.

  1974cited by this paper
• Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.

  1974cited by this paper
• Ineffectiveness of Glucose, Potassium, and Insulin Infusion During Pacing Stress in Chronic Ischemic Heart Disease

  1974cited by this paper
• Myocardial energy metabolism.

  1974cited by this paper
• Substrate competition in human myocardial metabolism.

  1974cited by this paper
• Present-day management of acute myocardial infarction: an outline of policy and practice in the Myocardial Infarction Research Unit at the University of Alabama in Birmingham.

  1973cited by this paper
• The Glucose‐Insulin‐Potassium (GIK) Regimen in the Treatment of Myocardial Ischemia

  1973cited by this paper
• Glucose, insulin, potassium in acute myocardial infarction.

  1973cited by this paper
• Hemodynamic monitoring in a coronary intensive care unit: clinical application.

  1972cited by this paper
• Enhancement of myocardial function during hypoxia by increased glucose availability

  1972cited by this paper
• Effect of Glucose‐Insulin‐Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion

  1972cited by this paper
• Metabolic Response during Impending Myocardial Infarction: II. Clinical Implications

  1972cited by this paper
• Metabolic Response during Impending Myocardial Infarction: I. Relevance of Studies of Glucose and Fatty Acid Metabolism in Animals

  1972cited by this paper
• Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart.

  1972cited by this paper
• The Role of Free Fatty Acids in the Production of Ventricular Arrhythmias after Acute Coronary Artery Occlusion

  1971cited by this paper
• Failure of high concentrations of circulating free fatty acids to provoke arrhythmias in experimental myocardial infarction.

  1971cited by this paper
• Plasma free fatty acid and catecholamine levels in patients with acute myocardial infarction.

  1971cited by this paper
• Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.

  1971cited by this paper
• A metabolic cause for arrhythmias during acute myocardial hypoxia.

  1970cited by this paper
• The glucose hypothesis: Relation to acute myocardial ischaemia

  1970cited by this paper
• Heparin and ventricular arrhythmias after myocardial infarction.

  1970cited by this paper
• Effect of Heparin on Serum Free-fatty-acids, Plasma Catecholamines, and the Incidence of Arrhythmias following Acute Myocardial Infarction

  1970cited by this paper
• A new coronary prognostic index.

  1970cited by this paper
• Depression of Myocardial Contractility in Rats by Free Fatty Acids during Hypoxia

  1970cited by this paper
• Potassium, glucose, and insulin treatment for acute myocardial infarction.

  1969cited by this paper
• Serum-free-fatty-acids and their relation to complications after acute myocardial infarction.

  1969cited by this paper
• Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction

  1969cited by this paper
• Potassium, glucose, and insulin in myocardial infarction.

  1969cited by this paper
• A new coronary prognostic index.

  1969cited by this paper
• The Depressant Effect of Fatty Acids on the Isolated Rabbit Heart∗

  1969cited by this paper
• Heparin and human lipid metabolism.

  1969cited by this paper
• Acute effects of increased serum osmolality on left ventricular performance.

  1969cited by this paper
• Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction.

  1969cited by this paper
• Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction.

  1968cited by this paper
• "Polarizing" solutions in patients with acute myocardial infarction. A double-blind study with negative results.

  1968cited by this paper
• Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

  1968cited by this paper
• Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

  1967cited by this paper
• Potassium, glucose, and insulin in treatment of myocardial infarction.

  1967cited by this paper
• Potassium, glucose, and insulin in myocardial infarction.

  1967cited by this paper
• Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion.

  1966cited by this paper
• Effect of free fatty acid on the oxygen consumption of perfused rat heart.

  1966cited by this paper
• EMERGENCY HYPOTHERMIC IN MENINGOCOCCAL MENINGITIS.

  1965cited by this paper
• Influence of Glucose on the Transmembrane Action Potential of Anoxic Papillary Muscle

  1965cited by this paper
• Potassium, glucose, and insulin in treatment of myocardial infarction.

  1965cited by this paper
• THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

  1964cited by this paper
• The polarizing treatment of acute myocardial infarction. Possibility of its use in other cardiovascular conditions.

  1963cited by this paper
• MYOCARDIAL ARTERIOVENOUS DIFFERENCES OF INDIVIDUAL FREE FATTY ACIDS IN HEALTHY HUMAN INDIVIDUALS.

  1963cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper
• Myocardial removal of free fatty acids under normal pathological conditions.

  1962cited by this paper
• Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report.

  1962cited by this paper
• A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION

  1962cited by this paper
• Myocardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads.

  1961cited by this paper
• Effect of glucose and insulin on the esterification of fatty acids by isolated adipose tissue.

  1960cited by this paper
• Myocardial metabolism of fatty acids.

  1960cited by this paper
• Studies on rat adipose tissue in vitro. V. Effects of glucose and insulin on the metabolism of palmitate-1-C14.

  1960cited by this paper
• Production of Unesterified Fatty Acids from Isolated Rat Adipose Tissue Incubated in vitro.

  1958cited by this paper
• Unesterified fatty acid in human blood plasma.

  1956cited by this paper
• Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart.

  1955cited by this paper
• Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism.

  1954cited by this paper
• Metabolic studies on the human heart in vivo

  1953cited by this paper
• Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart.

  1953cited by this paper
• Factors affecting the response of immunized guinea pigs to antigenic stimulus; further observations.

  1949cited by this paper

• Effect of Insulin on Natriuretic Peptide Gene Expression in Porcine Heart.

  2020cites this paper
• Does Tight Glucose Control During the First 24 hours of Hospitalization Reduce Scintigraphic Infarct Size in STEMI Patients?

  2020cites this paper
• Protective and curative effects of Beta vulgaris on pesticide dimethyl 2,2-dichlorovinyl phosphate-exposed albino rats

  2019cites this paper
• Protective and curative effects of on dimethyl Beta vulgaris

  2019cites this paper
• Non-diabetic clinical applications of insulin

  2016cites this paper
• Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.

  2016cites this paper
• Common variants associated with changes in levels of circulating free fatty acids after administration of glucose–insulin–potassium (GIK) therapy in the IMMEDIATE trial

  2015cites this paper
• Citric Acid Cycle Intermediates in Cardioprotection

  2014cites this paper
• 712 Circ Cardiovasc Genet October 2014 acute myocardial infarction

  2014cites this paper
• ovine diabetes Glucose-insulin-potassium solution improves left ventricular energetics in chronic

  2013cites this paper
• Molecular and Cellular Signaling Mechanisms Elucidating Aldose Reductase Mediated Ischemia-Reperfusion Injury in the Myocardium

  2012cites this paper
• randomized trial for acute myocardial infarction: The glucose-insulin-potassium study: a Glucose-insulin-potassium infusion inpatients treated with primary angioplasty

  2011cites this paper
• Insulin resistance and progression of heart failure in the older adult

  2011cites this paper
• the effect of insulin on the heart Part 1 : Effects on metabolism and function

  2010cites this paper
• The effect of insulin on the heart

  2010cites this paper
• The effect of insulin on the heart

  2010cites this paper
• Diabetes and cardiovascular outcomes: finding the silver lining.

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Acute myocardial infarction, hyperglycemia, and insulin.

  2009cites this paper
• Insulin therapy for improving cardiac surgical outcomes.

  2009cites this paper
• Metabolic aspects of rhythm disturbances.

  2009cites this paper
• Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.

  2008cites this paper
• Use of Insulin to Improve Glycemic Control in Diabetes Mellitus

  2008cites this paper
• Intensive insulin therapy終了後，心不全を契機に重篤な高カリウム血症をきたした心臓外科術後の1症例

  2008cites this paper
• Potential use of insulin as an anti‐inflammatory drug

  2008cites this paper
• Effects of intermittent and long-term glucose-insulin-potassium infusion in patients with systolic heart failure.

  2008cites this paper
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  2007cites this paper
• Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease.

  2007cites this paper
• Effect of hyperglycemia and insulin in acute coronary syndromes.

  2007cites this paper
• Mechanism by which hyperglycemia plays a role in the setting of acute cardiovascular illness.

  2006cites this paper
• Glucose, insulin and myocardial ischaemia

  2006cites this paper
• Intravenous glucose–insulin–potassium during off‐pump coronary artery bypass surgery does not reduce myocardial injury

  2006cites this paper
• Glucose-insulin-potassium infusion in acute myocardial infarction: a hemodynamic study.

  2006cites this paper
• Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?

  2006cites this paper
• Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction.

  2006cites this paper
• Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.

  2006cites this paper
• Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose.

  2006cites this paper
• ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.

  2005cites this paper
• Coronary Artery Disease and Arrhythmias Efficacy of Metabolic Support With Glucose-Insulin-Potassium for Left Ventricular Pump Failure After Aortocoronary Bypass Surgery

  2005cites this paper
• Metabolic interventions in acute myocardial infarction

  2005cites this paper
• A challenge to the metabolic approach to myocardial ischaemia.

  2005cites this paper
• Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).

  2005cites this paper
• Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.

  2005cites this paper
• Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.

  2005cites this paper
• Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.

  2005cites this paper
• The measurement and cotrrol of myocardial infarct size

  2005cites this paper
• Hypothesis: normalisation of cytokine dysbalance explains the 143 favourable effects of strict glucose regulation in the critically ill

  2004cites this paper
• Hypothesis: Normalisation of cytokine dysbalance explains the favourable effects of strict glucose regulation in the critically ill.

  2004cites this paper
• Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

  2004cites this paper
• Myocardial infarction and glucose-insulin-potassium infusion: an overview

  2004cites this paper
• [Off-pump endovascular treatment of aortic arch aneurysms].

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• [Insulin in acute coronary syndromes].

  2004cites this paper
• Intravenous amiodarone in acute anterior myocardial infarction: A controlled study

  2004cites this paper
• Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.

  2004cites this paper
• Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes.

  2004cites this paper
• Glucose-insulin-potassium therapy for acute myocardial infarction: what goes around comes around.

  2004cites this paper
• Cardiogenic Shock and Heart Failure Complicating Acute Myocardial Infarction

  2004cites this paper
• An overview of the role of insulin in the treatment of hyperglycemia during acute myocardial ischemia.

  2004cites this paper
• The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes

  2004cites this paper
• Myocardial infarction and glucose-insulin-potassium infusion : an overview Summary

  2004cites this paper
• Glucose control during cardiac surgery: How sweet it is.

  2003cites this paper
• Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine

  2003cites this paper
• Aldose reductase: a novel target for cardioprotective interventions.

  2003cites this paper
• Therapy with insulin in cardiac surgery: controversies and possible solutions.

  2003cites this paper
• Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

  2003cites this paper
• Insulin and myocardial blood flow.

  2003cites this paper
• Optimal care of patients with type 2 diabetes mellitus and coronary artery disease.

  2003cites this paper
• Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy

  2002cites this paper
• Acute coronary syndromes

  2002cites this paper
• Is insulin an endogenous cardioprotector?

  2002cites this paper
• Is insulin an endogenous cardioprotector?

  2002cites this paper
• Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes.

  2002cites this paper
• A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis.

  2002cites this paper
• Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

  2001cites this paper
• Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels.

  2001cites this paper
• Cardiopulmonary resuscitation and emergency cardiovascular care. Acute coronary syndromes.

  2001cites this paper
• Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease

  2001influential citation
• Is insulin an antiinflammatory molecule?

  2001cites this paper
• Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect?

  2001cites this paper
• Part 7 : The Era of Reperfusion Section 1 : Acute Coronary Syndromes ( Acute Myocardial Infarction ) Major Guidelines Recommendations Prehospital Care

  2000cites this paper
• Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction

  2000cites this paper
• [Glucose-insulin-potassium (GIK) in prevention and therapy of myocardial ischemia].

  2000cites this paper
• Infarction ) Part 7 : The Era of Reperfusion : Section 1 : Acute Coronary Syndromes ( Acute Myocardial

  2000cites this paper
• Myocardial Ischaemia and Neuroendocrine Stress: Metabolic Consequences and Possibilities

  2000cites this paper
• Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.

  2000cites this paper
• Part 7: the era of reperfusion. Section 1: acute coronary syndromes (acute myocardial infarction). European Resuscitation Council.

  2000cites this paper
• Optimal dosage of insulin and glucose in glucose-insulin-potassium treatment of acute myocardial infarction remains to Be established

  1999cites this paper
• Ischemic preconditioning and glucose metabolism during low-flow ischemia: role of the adenosine A1 receptor.

  1999cites this paper
• Glucose for the heart.

  1999cites this paper
• Low-Dose Glucose-Insulin-Potassium Is Ineffective in Acute Myocardial Infarction: Results of a Randomized Multicenter Pol-GIK Trial

  1999cites this paper
• Metabolic intervention for the ischemic and post-ischemic heart.

  1999cites this paper
• Glucose, insulin, potassium (GIK) and the concept of metabolic support for the postischaemic heart

  1999cites this paper
• Ischemic preconditioning and glucose metabolism during low-flow ischemia : Role of the adenosine A1 receptor

  1999cites this paper
• Glucose for the Heart Current

  1999cites this paper
• [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments against].

  1998cites this paper
• La terapia con glucosa-insulina-potasio reduce las complicaciones en la fase aguda del infarto de miocardio. Argumentos en contra

  1998cites this paper
• Coronary heart disease in UK Indian Asians: the potential for reducing mortality

  1997cites this paper
• Substrate metabolism as a determinant for postischemic functional recovery of the heart.

  1997cites this paper
• Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

  1997cites this paper